Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Gastric Cancer

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 23 articles: HTML format

Single Articles

November 2023
1. DEPOTTE L, Palle J, Rasola C, Broudin C, et al
   New developments and standard of care in the management of advanced gastric cancer.
   Clin Res Hepatol Gastroenterol. 2023 Nov 10:102245.
   PubMed     Abstract available
   
   
   August 2023
2. DU C, He Z, Li L, Ning B, et al
   Endoscopic resection for the treatment of non-gastric gastrointestinal stromal tumors: A retrospective study from a large tertiary hospital in China.
   Clin Res Hepatol Gastroenterol. 2023;47:102152.
   PubMed     Abstract available
   
   
   January 2023
3. WANG M, Su J, Lu J, Yang Z, et al
   Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?
   Clin Res Hepatol Gastroenterol. 2023;47:102078.
   PubMed     Abstract available
   
   
   December 2022
4. YUAN H, Duan DD, Zhang YJ
   Comprehensive analysis of treatment-related adverse events of immunotherapy in advanced gastric or gastroesophageal junction cancer: A meta-analysis of randomized controlled trials.
   Clin Res Hepatol Gastroenterol. 2022;46:102031.
   PubMed     Abstract available
   
   
   October 2022
5. WU H, Jiang HJ, Wang SL, Chen XY, et al
   Impact of metabolic syndrome on the short- and long-term outcomes for the elderly patients with gastric cancer after radical gastrectomy.
   Clin Res Hepatol Gastroenterol. 2022;46:102041.
   PubMed     Abstract available
   
   
   May 2022
6. MA N, Qiao H, Tao H, Gan X, et al
   Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients.
   Clin Res Hepatol Gastroenterol. 2022 May 27:101962.
   PubMed     Abstract available
   
   
   
7. SIRMAI L, Benusiglio PR, Svrcek M, Dray X, et al
   Magnifying chromoendoscopy with targeted biopsies of intramucosal signet cell adenocarcinomas in a CDH1 pathogenic variant asymptomatic carrier.
   Clin Res Hepatol Gastroenterol. 2022;46:101914.
   PubMed    
   
   
   April 2022
8. CARBONI F, Zazza S, Bertini L, Diodoro MG, et al
   Remarkable survival of operated stage IV gastric cancer with resected late isolated colon metastasis.
   Clin Res Hepatol Gastroenterol. 2022 Apr 7:101917.
   PubMed     Abstract available
   
   
   
9. NG HI, Li ZQ, Zhang YM, Hu CF, et al
   Gastric inverted hyperplastic polyp, an exceptional case diagnosed after endoscopic submucosal dissection.
   Clin Res Hepatol Gastroenterol. 2022;46:101890.
   PubMed     Abstract available
   
   
   March 2022
10. HE T, Yu D, Wang Z, Guo C, et al
    Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: a long-term follow-up study.
    Clin Res Hepatol Gastroenterol. 2022 Mar 25:101913.
    PubMed     Abstract available
    
    
    
11. LI J, Huang WF, Zhang JY
    A rare case of duodenal neuroendocrine tumor with hepatic metastasis.
    Clin Res Hepatol Gastroenterol. 2022;46:101850.
    PubMed    
    
    
    
12. JENVRIN A, Lepine C, Bozec PL, Taieb J, et al
    Atypical cutaneous metastases of poorly cohesive carcinoma of the stomach: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2022;46:101795.
    PubMed    
    
    
    October 2021
13. TAJA-CHAYEB L, Vidal-Millan S, Trejo-Becerril C, Perez-Cardenas E, et al
    Hereditary Diffuse Gastric Cancer (HDGC). An overview.
    Clin Res Hepatol Gastroenterol. 2021 Oct 14:101820.
    PubMed     Abstract available
    
    
    September 2021
14. BOEKEN T, Gallois C, Douard R, Meatchi T, et al
    Bridge to surgery after irinotecan-based liver chemoembolization for metastatic gastric adenocarcinoma: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2021;45:101557.
    PubMed    
    
    
    July 2021
15. LIU H, Liu M, He B, Li Q, et al
    Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways.
    Clin Res Hepatol Gastroenterol. 2021 Jul 28:101779.
    PubMed     Abstract available
    
    
    
16. TRAN-MINH ML, Lehmann-Che J, Lambert J, Theou-Anton N, et al
    Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01.
    Clin Res Hepatol Gastroenterol. 2021;45:101691.
    PubMed     Abstract available
    
    
    June 2021
17. HOU B, Wang P, Liu T, Chen S, et al
    Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors.
    Clin Res Hepatol Gastroenterol. 2021 Jun 25:101748.
    PubMed     Abstract available
    
    
    May 2021
18. DOUMBE-MANDENGUE P, Beuvon F, Belle A, Dermine S, et al
    Outcomes of endoscopic submucosal dissection for early esophageal and gastric cardia adenocarcinomas.
    Clin Res Hepatol Gastroenterol. 2021;45:101700.
    PubMed     Abstract available
    
    
    March 2021
19. BU X, Chen Z, Zhang A, Zhang X, et al
    Circular RNA CircAFF2 Accelerates Gastric Cancer Development by Activating MiR-6894-5p and Regulating ANTXR 1 Expression.
    Clin Res Hepatol Gastroenterol. 2021 Mar 12:101671.
    PubMed     Abstract available
    
    
    
20. JIN P, Ji X, Ma S, Kang W, et al
    Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node.
    Clin Res Hepatol Gastroenterol. 2021;45:101634.
    PubMed     Abstract available
    
    
    January 2021
21. CARBONE R, Vanoli A, Rovedatti L, Lucioni M, et al
    Epstein-Barr virus negative smooth muscle neoplasm of the stomach in a young woman.
    Clin Res Hepatol Gastroenterol. 2021;45:101471.
    PubMed     Abstract available
    
    
    November 2020
22. YAN XL, Luo QY, Zhou SN, Pan WT, et al
    MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
    Clin Res Hepatol Gastroenterol. 2020 Nov 30:101574.
    PubMed     Abstract available
    
    
    
23. LU J, Ma Y, Zhao Z
    MiR-142 suppresses progression of gastric carcinoma via directly targeting LRP8.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101520.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.